·   Log in

Archive for November 5th, 2009

US FDA speeds up review for velaglucerase alfa to treat Gaucher disease: Shire

Thursday, November 5, 2009 15:15

Velaglucerase alfa, an enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease, has been granted priority review by the United States Food and Drug Administration, maker of the drug Shire plc announced.

This was posted under category: Biotech  |  Read Full Story  |  0 Comments
Tagged with: ,

Ranbaxy honours scientists & young scholars in pharma and medicine research

Thursday, November 5, 2009 15:14

Ranbaxy Science Foundation (RSF), a non-profit organization set-up by Ranbaxy Laboratories Limited (RLL), has honoured Indian researchers in pharma and medicine for their outstanding contributions in its 21st Annual Research Awards for the year 2008

This was posted under category: Pharma  |  Read Full Story  |  0 Comments
Tagged with:

Non opium pain drug tezampanel can treat acute migraine, says Raptor

Thursday, November 5, 2009 13:11

Tezampanel, a non opium based pain killer by Raptor Pharmaceutical Corporation, has been found effective in dealing with acute migraine and other neuropathic pain. 

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments

Anti-flu drug laninamivir by Daiichi Sankyo to be launched by 2011

Thursday, November 5, 2009 13:11

Laninamivir, an inhaled drug to treat H1N1 swine flu, is also found effective against H5N1 avian influenza

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with:

Miconazole single dose is effective and safe to treat candidiasis in HIV patients: BioAlliance Pharma

Thursday, November 5, 2009 10:36

Clotrimazole, current treatment against oral candidiasis is administered five times a day

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with: